Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2007 | 03-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,072 | -3,300 | N/A | N/A | N/A |
| Depreciation Amortization | 13 | 16 | N/A | N/A | N/A |
| Accounts receivable | 115 | 531 | N/A | N/A | N/A |
| Other Working Capital | 334 | 234 | N/A | N/A | N/A |
| Other Operating Activity | 407 | -114 | 0 | 0 | 0 |
| Operating Cash Flow | $-3,203 | $-2,634 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -10 | N/A | N/A | N/A |
| Investing Cash Flow | $-1 | $-10 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 182 | 56 | N/A | N/A | N/A |
| Debt Repayment | -40 | -18 | N/A | N/A | N/A |
| Common Stock Issued | 7,738 | 2,743 | N/A | N/A | N/A |
| Other Financing Activity | -842 | -450 | 0 | 0 | 0 |
| Financing Cash Flow | $7,038 | $2,330 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -9 | 85 | N/A | N/A | N/A |
| Beginning Cash Position | 4,076 | 4,360 | N/A | N/A | N/A |
| End Cash Position | 7,901 | 4,131 | N/A | N/A | N/A |
| Net Cash Flow | $3,826 | $-229 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,203 | -2,634 | N/A | N/A | N/A |
| Capital Expenditure | -1 | -10 | N/A | N/A | N/A |
| Free Cash Flow | -3,204 | -2,644 | 0 | 0 | 0 |